These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6334044)

  • 21. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
    Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis.
    Miyauchi A; Hiramine C; Tanaka S; Hojo K
    Tohoku J Exp Med; 1990 Oct; 162(2):147-67. PubMed ID: 2129070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Misgurnus anguillicaudatus polysaccharide on immune responses of splenocytes in mice.
    Qin CG; Huang KX; Xu HB
    Acta Pharmacol Sin; 2002 Jun; 23(6):534-8. PubMed ID: 12060528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of cyclophosphamide and thymostimulin treatment on the in vitro natural killer and candidacidal activity of murine spleen cells.
    Baccarini M; Scaringi L; Puccetti P; Falchetti R; D'Errico P; Bistoni F
    Int J Tissue React; 1984; 6(6):485-92. PubMed ID: 6530352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on induction and control of cell-mediated autoimmunity. I. Induction of "autoreactive" T lymphocytes in mice by cyclophosphamide.
    L'age-Stehr J; Diamantstein T
    Eur J Immunol; 1978 Sep; 8(9):620-4. PubMed ID: 309398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
    Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB; Fass L; Fefer A
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of CD8+ cytotoxic T cells by immunization with killed influenza virus and effect of cholera toxin B subunit.
    Mbawuike IN; Wyde PR
    Vaccine; 1993 Sep; 11(12):1205-13. PubMed ID: 7903015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imuthiol influences on cytotoxic T cells and NK activity in +/+ and athymic nude BALB/c mice.
    Florentin I; Chung V; Renoux M; Renoux G
    Immunopharmacol Immunotoxicol; 1989; 11(4):645-55. PubMed ID: 2560786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection.
    Qian JH; Kokudo S; Sato S; Hamaoka T; Fujiwara H
    Transplantation; 1987 Apr; 43(4):538-43. PubMed ID: 3495052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver injury due to sequential activation of natural killer cells and natural killer T cells by carrageenan.
    Abe T; Kawamura H; Kawabe S; Watanabe H; Gejyo F; Abo T
    J Hepatol; 2002 May; 36(5):614-23. PubMed ID: 11983444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells.
    Campanile F; Iorio AM; Bonmassar E
    Int J Immunopharmacol; 1984; 6(4):251-8. PubMed ID: 6480192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of cyclophosphamide treatment in murine lymphocytic choriomeningitis: evidence for cytotoxic T cell replication in vivo.
    Allan JE; Doherty PC
    Scand J Immunol; 1985 Oct; 22(4):367-74. PubMed ID: 3877978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
    Nio Y; Ohgaki K; Tobe T
    J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice.
    Nikcevich DA; Duffie GP; Young MR; Ellis NK; Kaufman GE; Wepsic HT
    Cell Immunol; 1987 Oct; 109(2):349-59. PubMed ID: 2959374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequencies of alloreactive and self-restricted cytotoxic T cell precursors during lymphatic regeneration.
    Buszello H; Pottmeyer C; Dröge W
    J Immunol; 1983 Aug; 131(2):548-50. PubMed ID: 6602837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG antibodies to asialoGM1 are more sensitive than IgM antibodies to kill in vivo natural killer cells and prematured cytotoxic T lymphocytes of mouse spleen.
    Fujii Y; Sendo F; Kamiyama T; Naiki M
    Microbiol Immunol; 1990; 34(6):533-42. PubMed ID: 2170825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.